Introspective Market Research (IMR) has unveiled its latest strategic analysis on the Global Osteogenesis Imperfecta (OI) Treatment Market . The report highlights the critical role of specialized pharmaceuticals and emerging gene therapies in managing this rare, inherited connective tissue disorder, often referred to as "brittle bone disease." The market, which was valued at USD 722.9 Million...